Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Business Tribune.
Press releases published on May 23, 2025
APPLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Apple Inc. on Behalf of Apple Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
LUNA INNOVATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Luna Innovation, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
ADTRAN ALERT: Bragar Eagel & Squire, P.C. is Investigating ADTRAN Holdings, Inc. on Behalf of ADTRAN Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
SEMLER ALERT: Bragar Eagel & Squire, P.C. is Investigating Semler Scientific Inc. on Behalf of Semler Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel …
Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock
GlobeNewswire
·
May 23, 2025
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of …
Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition
GlobeNewswire
·
May 23, 2025
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare and clinical stage drug development company, is pleased to announce …
CECOCECO to Unveil ArtMorph Innovation at AIA Conference on Architecture & Design 2025
GlobeNewswire
·
May 23, 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- CECOCECO, a leading innovator in the lighting and display industry, is excited to announce its participation in the AIA Conference on Architecture …
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm– UNH
GlobeNewswire
·
May 23, 2025
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and May 12, 2025, both dates inclusive (the “Class …
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 23, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, …